By Jonathan Bench, Attorney at Harris Bricken The U.S. hemp market continues to heat up for a variety of reasons, mainly because the general populace is finally starting to understand the difference between cannabis as marijuana and cannabis as hemp (and the benefits of CBD and other cannabinoids derived from cannabis). In this post I’ll […]
international
Hemp CBD Across Europe: The United Kingdom
By Nathalie Bougenies, Attorney at Harris Bricken The enactment of the 2018 Farm Bill and the legalization of hemp and hemp derivative including cannabidiol (“CBD”), has led to a massive CBD craze in the United States. The highly coveted cannabinoid is infused with everything: bath bombs, dog treats and even workout clothes (yes, workout clothes!). According […]
Cannabis and International Trade: Don’t Ignore the U.S.-China Trade War
By Griffen Thorne & Adams Lee, Attorneys at Harris Bricken Marijuana and hemp companies should not ignore the US-China trade war. Numerous products and components in these industries might be subject to increased tariffs of 25 percent. If cannabis companies can’t find new suppliers, those are costs that they will have to bear, or will have to pass […]
The California Bureau of Cannabis Control’s Final Regulations Immigration Impact on Foreign “Owners”
By Griffen Thorne & Akshat Divatia, Attorneys at Harris Bricken On January 16, 2019, each of the three California cannabis agencies dropped a final set of regulations. In many senses, the Bureau of Cannabis Control’s (“BCC”) regulations were the most comprehensive and expansive (we summarized some of the highlights here, and summarized the highlights of […]
Colombia’s Goal: Become First Major Marijuana Producer, Legally
Colombia gave a major push to rebooting its marijuana industry this week by awarding its first license for medical marijuana production to a Canadian company with big plans. The move marks a changing shift in attitudes toward cannabis in a country that has long been at the center of the U.S.-led war on drugs. Billions […]
